Regulation and control system for red light in microbial cells and preparation method and application thereof
Through the red light dynamic regulation system, gene expression is regulated in Saccharomyces cerevisiae, the problem of cell growth block caused by static regulation is solved, and the yield of β-carotene and vitamin D3 is improved, achieving high efficiency, low cost and low environmental impact Production.
Patent Information
- Application Number
- CN202410990678.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-12
AI Technical Summary
The static regulatory system in microbial cells causes gene expression levels to not adapt to changes in metabolic pathways, causing cell growth blocks, and the production of β-carotene and vitamin D3 in chemical synthesis and biological extraction methods has environmental pollution, high cost and low yield. The problem.
A dynamic red light regulation system was constructed, and the photosensitive proteins PhyA and FHY1 were used to accurately regulate the gene expression of Saccharomyces cerevisiae strains through red light induction, achieving a balance between cell growth and metabolites accumulation, and fermentation and production was used as the chassis strain.
The yield of β-carotene and 7-DHC was significantly improved, 25 times and 20 times higher than conventional methods, achieving low toxicity, low cost and low environmental impact production, simplifying the induction process, and reducing other light sources toxicity and interference of cells.
Smart Images

Figure CN118931937A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of gene modification technology, and in particular to a red light regulation system in microbial cells and a preparation method and application thereof. Background Art
[0002] The green, efficient and low-cost production of compounds using microbial cell factories has become a highly promising sustainable alternative. Compared with chemical synthesis and biological extraction, microbial fermentation has low environmental pressure and short fermentation cycle, and has a very broad application prospect.
[0003] In this field, the metabolic pathway of microorganisms is usually optimized to increase the yield of target products, and the optimization strategies include static regulation and dynamic regulation. Static regulation strategies include gene insertion and knockout, regulating promoter strength and ribosome binding sites, etc. to increase the conversion rate of substrates to target compounds, thereby increasing the yield of target products. However, static regulation needs to achieve the purpose of increasing yield by changing the metabolic pathway in the cell or introducing exogenous genes, breaking the balance between the production of target products and cell growth, and ultimately causing the product to be unable to be mass-produced. Therefore, the static regulation system often causes the expression level of the gene to be output without sensing changes in the metabolic pathway and the cell environment, causing cell growth retardation. On the contrary, the dynamic regulation system can regulate the metabolic state of the cell in real time by sensing the environment and intracellular signals. It can make the cells grow well and always keep the cells in the best state during the production stage, thereby effectively increasing the yield of the target product. Summary of the invention
[0004] To fill the gap in the prior art, the present invention provides a light control element, a red light dynamic control system and an application of the red light dynamic control system.
[0005] The inventive concept of the present invention is: the present invention constructs a red light dynamic regulation system, which has the advantages of low toxicity and artificially controlled synthesis pathways. The model microorganism Saccharomyces cerevisiae is used as a chassis strain, which has the characteristics of clear genetic background, easy genetic modification, short growth cycle, low culture cost, etc. Introducing the light control system into Saccharomyces cerevisiae to regulate gene expression can not only accurately regulate gene expression in time and space, but also effectively dissociate the growth and production stages of cells, and effectively improve the production performance of the strain. Photosensitive protein is the core component of the light regulation system. The inventors of the present invention found that among many photosensitive proteins, the plant photosensitive pigment PhyA regulated by red light has the characteristics of low toxicity to cells, strong tissue penetration, and fast light activation response speed. At the same time, the effect of PhyA and FHY1 is stronger than PhyB / PIF3. It is more conducive to regulating the balance between bacterial growth and metabolite accumulation.
[0006] The primary purpose of the present invention is to provide a light-control element, wherein the primer sequence of the light-control element I PhyA (1-1126aa) is shown in SEQ ID No: 1-2.
[0007] The primer sequences of the light-control element II PhyA mutant (1-412aa) are shown in SEQ ID Nos: 3-4.
[0008] The primer sequences of the light-control element III PhyA (1-591aa) are shown in SEQ ID Nos: 5-6.
[0009] The primer sequence of the light-control element IVFHY1 (1-202aa) is shown in SEQ ID No: 7-8.
[0010] The primer sequences of the light-control element ⅤFHY1 (167-202aa) are shown in SEQ ID Nos: 9-10.
[0011] The primer sequences of GAL4BD of the present invention are shown in SEQ ID Nos: 11-12.
[0012] The primer sequences of VP64 of the present invention are shown in SEQ ID Nos: 13-14.
[0013] The present invention also seeks to protect a light control system constructed by the light control element.
[0014] The light control system is obtained by inserting a linearized vector obtained by recombination of any one of PhyA (1-1126aa), PhyA (1-412aa), and PhyA (1-591aa) with the GAL4BD gene into a vector obtained by recombination of any one of FHY1 (1-202aa), FHY1 (167-202aa) with the VP64 gene to obtain the light control system.
[0015] As a preferred embodiment of the present invention, the method for constructing the light control system is:
[0016] The pYES2-Kan expression vector was digested with BamH I, and after the digestion of the vector, it was recombined and connected with any one of the light-control elements I to III and the GAL4BD gene, and a single clone was picked on a plate for colony PCR identification. One of the primers PhyA (1-1126aa)-F or PhyA (1-591aa)-F or PhyA (1-412aa)-F corresponding to the above light-control element and the primer GAL4BD-R were used to amplify the target fragment; after the bacterial solution was expanded and the recombinant plasmid was extracted, it was verified whether the target gene was inserted into the pYES2-Kan vector, and BamH I was used for enzyme digestion verification.
[0017] The above expression vector is digested with Sac I to obtain a linearized vector. After the linearized vector is recombined with the light-controlled element IV or V and the artificially synthesized VP64 gene, a single clone is picked on a plate for colony PCR identification, and the target fragment is amplified using one of FHY1 (1-202aa) -F or FHY1 (167-202aa) -F and the gene VP64-R as primers; after the bacterial liquid is expanded and the recombinant plasmid is extracted, it is verified whether the target gene is inserted into the vector, and Sac I is used for enzyme digestion verification.
[0018] The present invention also seeks to protect the application of the above light control system in producing terpenoid compounds, wherein the terpenoid compounds include but are not limited to β-carotene, α-carotene, lycopene, zeaxanthin, and lutein.
[0019] β-Carotene belongs to tetraterpenoid compounds and has high nutritional value. β-Carotene is produced by chemical synthesis or extraction from plants. β-Carotene produced by chemical synthesis is synthesized by a series of chemical reactions using organic chemical raw materials. Carotenoids and proteins in plants generally exist in a combined state. Using the traditional direct extraction method, the crude β-carotene pigment obtained after concentration contains a certain amount of alcohol-soluble protein, which is not conducive to purification and causes pollution to the environment. In addition, due to the long growth cycle of plants, growth is easily affected by natural factors such as light, region, and season. The plant extraction method also has the disadvantages of low zeaxanthin content in plants, high extraction cost, and difficult production process control.
[0020] However, there are some problems and shortcomings in the synthesis of β-carotene by plant extraction and chemical synthesis. The growing demand requires the development of alternative sources, so heterologous synthesis of β-carotene in microorganisms is currently a very promising production method. The present invention uses a transfer light-controlled system microbial fermentation to provide an alternative and sustainable way to produce β-carotene, providing additional advantages such as high product yield, low material cost and low environmental impact.
[0021] A fermentation method for constructing a terpene compound-producing yeast strain comprises the following steps:
[0022] The correct positive monoclonal strain was picked and cultured in SD-Met-URA medium to prepare fermentation seed liquid. The seed liquid was transferred to 100 mL YPD medium at a 5% inoculation rate and cultured at 28°C and 180 rpm for 2-3 days.
[0023] Transfer the Saccharomyces cerevisiae containing the light-controlled inducible plasmid and perform the red light response performance test. The culture medium is SD-Met-URA3, and the liquid volume is 25 / 100 (i.e., 25 mL of SD-Met-URA3 culture medium is placed in a 100 mL conical flask). Cultivate in a constant temperature shaker (28°C, 180-200 r / min) equipped with a red light lamp (600-700 nm) for 72-120 h, with light on every 1-6 h and stop light for 1-6 h. Take samples to measure RFU and OD 600 The induction effect was evaluated by the value, and three replicates were set for each group. During the culture test, the inoculation was carried out at an inoculation amount of 1-5%.
[0024] The present invention also seeks to protect the application of the above-mentioned light-controlled system in the production of steroidal compounds, such as vitamin D3 precursor 7-DHC.
[0025] Vitamin D is a fat-soluble vitamin necessary for maintaining the health and normal growth of the body. It has important application value in the fields of daily chemical industry, medicine and food. Vitamin D mainly has two forms, namely vitamin D2 and vitamin D3, but studies have shown that vitamin D3 can be converted into 1,25-(OH)2D3 to exert physiological activity in a more effective form. The market demand for vitamin D3 is increasing year by year. The main method for industrial production of vitamin D3 is chemical synthesis, which has low product purity and many by-products; biological extraction can also prepare vitamin D3, but there are problems such as low extraction efficiency, high cost and unstable production, which makes it difficult to achieve industrial production. At present, the production of vitamin D3 by microbial fermentation is mainly through the construction of metabolic synthesis pathways in microorganisms, using simple carbon sources as substrates, biosynthesizing 7-dehydrocholesterol (7-DHC), an important precursor of vitamin D3, and further obtaining vitamin D3 through photoisomerization. Saccharomyces cerevisiae has been preferentially used as chassis cells for the synthesis of 7-DHC because of its advantages such as short growth cycle, easy genetic manipulation, and sterol biosynthesis module.
[0026] A fermentation method for constructing a steroid-producing yeast strain comprises the following steps:
[0027] The correct positive monoclonal strain was picked and cultured in SD-Met-URA medium to prepare fermentation seed liquid. The seed liquid was transferred to 100 mL YPD medium at a 5% inoculation rate and cultured at 30°C and 200 rpm for 2-3 days.
[0028] Transfer the Saccharomyces cerevisiae containing the light-controlled inducible plasmid and perform a red light response performance test. The culture medium is SD-Met-URA3, and the liquid volume is 25 / 100 (i.e., 25 mL of SD-Met-URA3 culture medium is placed in a 100 mL conical flask). Cultivate in a constant temperature shaker (30°C, 180-200 r / min) equipped with a red light lamp (600-700 nm) for 48-120 h, with light on every 1-12 h and stop light for 1-12 h. Take samples to measure RFU and OD 600 The induction effect was evaluated by the value, and three replicates were set for each group. During the culture test, the inoculation was carried out at an inoculation amount of 2-4%.
[0029] Compared with the prior art, the present invention has the following advantages:
[0030] 1. The present invention obtains red light regulatory elements and constructs a yeast system for red light regulated gene expression. The system dynamically regulates the balance between bacterial growth and accumulation of metabolites through red light, thereby alleviating the problem of excessive product accumulation inhibiting cell growth.
[0031] 2. The yield of induced synthesis of 7-DHC by the dynamic control system of the present invention is significantly increased, 25 times higher than that of conventional methods.
[0032] 3. The dynamic control system of the present invention can significantly increase the yield of induced synthetic carotenoids, which is 20 times higher than that of conventional methods.
[0033] 4. The red light induction method used in the present invention is simple and does not require the addition of any organic or toxic reagents.
[0034] 5. The light control system of the present invention uses red light with higher penetrating power, which reduces the toxicity and interference of other light sources on cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 Comparison results of β-carotene production differences under red light regulation;
[0036] Figure 2 Comparison results of 7-DHC production differences under red light regulation;
[0037] Figure 3 DNA electrophoresis of the light-controlled element FHY1 (127-202aa);
[0038] Figure 4 DNA electrophoresis of the light-controlled element PHYA (1-412aa);
[0039] Figure 5 DNA electrophoresis of the light-controlled element PHYA (1-591aa);
[0040] Figure 6DNA electrophoresis of the light-controlled element PHYA (1-1126aa);
[0041] Figure 7 DNA electrophoresis of the light-controlled element FHY1 (1-202aa). DETAILED DESCRIPTION
[0042] In order to more clearly illustrate the purpose, technical solutions and advantages of the present disclosure, the embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings. It should be understood that the following description of the embodiments is intended to explain and illustrate the overall concept of the present invention, and should not be understood as a limitation of the present invention. In the specification and the drawings, the same or similar figure marks refer to the same or similar parts or components. For the sake of clarity, the drawings are not necessarily drawn to scale, and some well-known parts and structures may be omitted in the drawings. Unless otherwise specified, the experimental methods used in the present invention are all conventional methods, and the experimental equipment, materials, reagents, etc. used can be obtained from commercial channels.
[0043] In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc., indicating the orientation or positional relationship, are based on the orientation or positional relationship shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and cannot be understood as indicating or implying relative importance.
[0044] In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected" and "connected" should be understood in a broad sense. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood in specific circumstances.
[0045] In addition, the technical features involved in the different embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0046] Example 1 Obtaining GAL80 gene knockout yeast H1
[0047] The designed GAL80 knockout cassette is: GAL80 upper homologous segment-loxp-URA3 expression cassette-loxp-GAL80 lower homologous segment. The URA3 expression cassette was amplified using primers URA-F and URA-R; the GAL80 upper homologous segment and lower homologous segment were amplified from the genome of Saccharomyces cerevisiae BY4741 using primers GAL80up-F, GAL80up-R and GAL80down-F, GAL80down-R, respectively. The above products were connected to the BamH I site of the expression vector pYES2-Kan using the homologous recombination method, and PCR cloning was performed using primers wGAL80up-F and wGAL80down-R to amplify the knockout expression cassette of the GAL80 gene, which was transformed into the competent state of the Saccharomyces cerevisiae BY4741 strain, spread on SD Ura plates, cultured at 30°C for 3 days, and colony PCR was performed to verify the strain H1.
[0048] Primer sequences:
[0049]
[0050] Example 2 Obtaining GAL4 gene knockout yeast H2
[0051] The designed GAL4 knockout cassette is: GAL4 upper homologous segment-Met expression cassette-GAL4 lower homologous segment. The Met expression cassette was amplified using primers Met-F and Met-R; the GAL4 upper homologous segment and lower homologous segment were amplified from the genome of Saccharomyces cerevisiae BY4741 using primers GAL4up-F, GAL4up-R and GAL4down-F, GAL4down-R, respectively. The above products were connected to the Sac I site of the expression vector pYES2-Kan by homologous recombination, and PCR cloning was performed using primers wGAL4up-F and wGAL4down-R to amplify the GAL4 knockout cassette. The knockout cassette was transferred into Saccharomyces cerevisiae BY4741 cells in which the GAL80 gene had been knocked out by electroporation, and positive clones were screened on SD Met plates, cultured at 30°C for 3 days, and colony PCR was performed to verify the strain H2.
[0052] Primer sequences:
[0053]
[0054] Example 3 Obtaining DNA Binding Protein GAL4BD and Transcription Activation Domain VP64
[0055] Using pGBKT7 as a template, the GAL4BD gene was amplified using the GAL4BD-linker-F and GAL4BD-R primers. The VP64 gene was artificially synthesized and amplified using the primers VP64-linker-F and VP64-R.
[0056] Primer sequences:
[0057]
[0058] Example 4 Obtaining light control elements of different lengths
[0059] The PhyA(1-1126aa) gene was amplified using primers PhyA(1-1126aa)-F and PhyA(1-1126aa)-linker-R.
[0060] The PhyA mutant (1-412aa) gene was amplified using primers PhyA (1-412aa)-F and PhyA (1-412aa)-linker-R.
[0061] The PhyA(1-591aa) gene was amplified using primers PhyA(1-591aa)-F and PhyA(1-591aa)-linker-R.
[0062] The FHY1(1-202aa) gene was amplified using primers FHY1(1-202aa)-F and FHY1(1-202aa)-linker-R.
[0063] The FHY1(167-202aa) gene was amplified using primers FHY1(167-202aa)-F and FHY1(167-202aa)-linker-R.
[0064] Primer sequences:
[0065]
[0066] Example 5 Construction of NTE-HKRD (1-1126aa)-FHY1 (1-202aa) element
[0067] The pYES2-Kan expression vector was digested with BamH I, and after the vector was digested and recombined with PhyA (1-1126aa) and GAL4BD genes, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using PhyA (1-1126aa)-F and GAL4BD-R as primers. After the bacterial liquid was expanded and the recombinant plasmid pYES2-Kan-PhyA (1-1126aa)-linker-GAL4BD was extracted, it was verified whether the target gene was inserted into the pYES2-Kan vector, and BamH I was used for restriction digestion verification.
[0068] The pYES2-Kan-PhyA(1-1126aa)-linker-GAL4BD expression vector was digested with Sac I to obtain a linearized vector, which was recombined with the FHY1(1-202aa) and VP64 genes. After transformation, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using FHY1(1-202aa)-F and VP64-R as primers. After the bacterial solution was expanded and the recombinant plasmid was extracted, it was verified whether the target gene was inserted into the vector pYES2-Kan-PhyA(1-1126aa)-linker-GAL4BD, and Sac I was used for restriction digestion verification.
[0069] Primer sequences:
[0070]
[0071] Example 6 Construction of NTE-PHY (1-591aa) - FHY1 (1-202aa) Components
[0072] The pYES2-Kan expression vector was digested with BamH I, and after the vector was digested, it was recombined with PhyA (1-591aa) and GAL4BD genes, and a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using PhyA (1-591aa)-F and GAL4BD-R as primers. After the bacterial liquid was expanded and the recombinant plasmid pYES2-Kan-PhyA (1-591aa)-linker-GAL4BD was extracted, it was verified whether the target gene was inserted into the pYES2-Kan vector, and BamH I was used for restriction digestion verification.
[0073] The pYES2-Kan-PhyA(1-591aa)-linker-GAL4BD expression vector was digested with Sac I to obtain a linearized vector and recombined with the FHY1(1-202aa) and VP64 genes. After transformation, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using FHY1(1-202aa)-F and VP64-R as primers. After the bacterial solution was expanded and the recombinant plasmid was extracted, it was verified whether the target gene was inserted into the vector pYES2-Kan-PhyA(1-591aa)-linker-GAL4BD, and Sac I was used for restriction digestion verification.
[0074] Primer sequences:
[0075]
[0076] Example 7 Construction of NTE-GAF (1-412aa) -FHY1 (1-202aa) element
[0077] The pYES2-Kan expression vector was digested with BamH I, and after the vector was digested, it was recombined with PhyA (1-412aa) and GAL4BD genes, and a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using PhyA (1-412aa)-F and GAL4BD-R as primers. After the bacterial liquid was expanded and the recombinant plasmid pYES2-Kan-PhyA (1-412aa)-linker-GAL4BD was extracted, it was verified whether the target gene was inserted into the pYES2-Kan vector, and BamH I was used for restriction digestion verification.
[0078] The pYES2-Kan-PhyA(1-412aa)-linker-GAL4BD expression vector was digested with Sac I to obtain a linearized vector, which was recombined with the FHY1(1-202aa) and VP64 genes. After transformation, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using FHY1(1-202aa)-F and VP64-R as primers. After the bacterial solution was expanded and the recombinant plasmid was extracted, it was verified whether the target gene was inserted into the vector pYES2-Kan-PhyA(1-412aa)-linker-GAL4BD, and Sac I was used for restriction digestion verification.
[0079] Primer sequences:
[0080]
[0081] Example 8 Construction of NTE-HKRD (1-1126aa))-FHY1 (167-202aa) element
[0082] The pYES2-Kan-PhyA(1-1126aa)-linker-GAL4BD expression vector was digested with Sac I, and after the linearized vector was recombined with FHY1(167-202aa) and VP64 genes, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using FHY1(167-202aa)-F and VP64-R as primers. After the bacterial liquid was expanded and the recombinant plasmid pYES2-Kan-PhyA(1-1126aa)-linker-GAL4BD-FHY1(167-202aa)-linker-VP64 was extracted, it was verified whether the target gene was inserted into the vector pYES2-Kan-PhyA(1-1126aa)-linker-GAL4BD-FHY1(1-202aa)-linker-VP64, and Sac I was used for restriction digestion verification.
[0083] Primer sequences:
[0084]
[0085] Example 9 Construction of NTE-PHY (1-591aa) - FHY1 (167-202aa) Components
[0086] The pYES2-Kan-PhyA(1-591aa)-linker-GAL4BD expression vector was digested with Sac I, and after the linearized vector was recombined with FHY1(167-202aa) and VP64 genes, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using FHY1(167-202aa)-F and VP64-R as primers. After the bacterial liquid was expanded and the recombinant plasmid pYES2-Kan-PhyA(1-591aa)-linker-GAL4BD-FHY1(167-202aa)-linker-VP64 was extracted, it was verified whether the target gene was inserted into the vector pYES2-Kan-PhyA(1-591aa)-linker-GAL4BD-FHY1(1-202aa)-linker-VP64, and Sac I was used for restriction digestion verification.
[0087] Primer sequences:
[0088]
[0089] Example 10 Construction of NTE-GAF (1-412aa) -FHY1 (167-202aa) element
[0090] The pYES2-Kan-PhyA(1-412aa)-linker-GAL4BD expression vector was digested with Sac I, and after the linearized vector was recombined with FHY1(167-202aa) and VP64 genes, a single clone was picked on the plate for colony PCR identification, and the target fragment was amplified using FHY1(167-202aa)-F and VP64-R as primers. After the bacterial liquid was expanded and the recombinant plasmid pYES2-Kan-PhyA(1-412aa)-linker-GAL4BD-FHY1(167-202aa)-linker-VP64 was extracted, it was verified whether the target gene was inserted into the vector pYES2-Kan-PhyA(1-412aa)-linker-GAL4BD-FHY1(1-202aa)-linker-VP64, and Sac I was used for restriction digestion verification.
[0091] Primer sequences:
[0092]
[0093] Example 11 Construction of a terpenoid-producing yeast strain for cultivation
[0094] The correct positive monoclonal strain was selected and cultured in SD-Met-URA3 medium at 28°C and 180 rpm for 2-3 days to prepare the fermentation seed solution.
[0095] Example 12 Construction of a steroid-producing yeast strain culture
[0096] The correct positive monoclonal strain was selected and cultured in SD-Met-URA3 medium at 30°C and 200 r / min for 2-3 days to prepare the fermentation seed solution.
[0097] Example 13 Construction of a red light-regulated terpene-producing Saccharomyces cerevisiae fermentation strain
[0098] The Saccharomyces cerevisiae containing the light-controlled induction plasmids of Examples 5-10 were transferred separately to test the red light response performance. The transparent conical flasks without tin foil were used as the induction experimental group, and the conical flasks wrapped with tin foil were used as the control group under dark conditions. The culture medium was SD-Met-URA3, and the liquid volume was 25 / 100 (25 mL of SD-Met-URA3 culture medium was contained in a 100 mL conical flask). Culture was carried out in a constant temperature shaker (28°C, 180-200 r / min) equipped with a red light lamp (600-700 nm) for 72-120 h, with illumination every 1-6 h and stopping illumination for 1-6 h. Sampling was performed to measure RFU and OD 600 The induction effect was evaluated by the value, and three replicates were set for each group. During the culture test, the inoculation was carried out at an inoculation amount of 1-5%.
[0099] Example 14 Construction of a steroid-producing Saccharomyces cerevisiae fermentation strain
[0100] The Saccharomyces cerevisiae containing the light-controlled induction plasmids of Examples 5-10 were transferred separately to test the red light response performance. The transparent conical flasks without tin foil were used as the induction experimental group, and the conical flasks wrapped with tin foil were used as the control group under dark conditions. The culture medium was SD-Met-URA3, and the liquid volume was 25 / 100 (25 mL of SD-Met-URA3 culture medium was contained in a 100 mL conical flask). Culture was carried out in a constant temperature shaker (30°C, 180-200 r / min) equipped with a red light lamp (600-700 nm) for 48-120 h, wherein the light was applied every 1-12 h and the light was stopped for 1-12 h. Sampling was performed to measure RFU and OD 600 The induction effect was evaluated by the value, and three replicates were set for each group. During the culture test, the inoculation amount was 2-4% (the inoculation amount was preferably 1%).
[0101] Example 157-DHC Detection
[0102] Take 2mL of fermentation liquid, centrifuge and discard the supernatant, add 200uL of dd H2O and resuspend the bacteria, break for 5min and discard the supernatant; add 1mL of KOH methanol solution, vortex and shake to mix, and saponify for 1-2h; then add 500-1000uL of n-hexane, mix thoroughly and centrifuge, draw the upper extract into 500ul n-hexane, mix thoroughly and centrifuge, and re-dissolve the product with 500ul of anhydrous ethanol; finally use for HPLC detection. HPLC liquid phase analysis of 7-dehydrocholesterol, set the conditions as column temperature 30℃, detection wavelength 280nm, flow rate 1ml / min, isocratic elution, and methanol as the mobile phase.
[0103] Example 16 β-carotene detection
[0104] Take 1mL of fermentation broth, centrifuge and discard the supernatant, centrifuge at 12000rmp for 2min, remove the supernatant, add 1mL of sterile ddH2O, centrifuge at 12000rmp for 2min, discard the supernatant, repeat once, add 1mL of acetone and crush for 5min, collect the supernatant acetone liquid, and finally use it for HPLC detection. The mobile phase is isopropanol:acetonitrile (1:1), the flow rate is 1.0mL / min, the column temperature is 28℃, and the detection wavelength is 450nm.
[0105] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical solutions and inventive concepts of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. Light control components, It is characterized in that The light control element includes any one of Ⅰ to Ⅴ, The primer sequence of the light control element I PhyA (1-1126aa) is shown in SEQ ID No: 1-2; The primer sequence of the light control element II PhyA (1-412aa) is shown in SEQ ID No: 3-4; The primer sequence of the light control element III PhyA (1-591aa) is shown in SEQ ID No: 5-6; The primer sequence of the light-control element IVFHY1 (1-202aa) is shown in SEQ ID No: 7-8; The primer sequences of the light-control element ⅤFHY1 (167-202aa) are shown in SEQ ID Nos: 9-10.
2. A dynamic light control system, It is characterized in that A light control system constructed by the light control element according to claim 1, The light control system is obtained by inserting a linearized vector obtained by recombination of any one of PhyA (1-1126aa), PhyA (1-412aa), and PhyA (1-591aa) with the GAL4BD gene into a vector obtained by recombination of any one of FHY1 (1-202aa), FHY1 (167-202aa) with the VP64 gene to obtain the light control system.
3. The dynamic light control system according to claim 2, It is characterized in that The primer sequences of GAL4BD are shown in SEQ ID Nos: 11-12; the primer sequences of VP64 are shown in SEQ ID Nos: 13-14.
4. The method for constructing a light control system according to claim 2, It is characterized in that The pYES2-Kan expression vector was digested with BamH I, and after the digestion of the vector, it was recombined with any one of the light-control elements I to III and the GAL4BD gene, and a single clone was picked on the plate for colony PCR identification. One of the primers PhyA (1-1126aa) -F or PhyA (1-591aa) -F or PhyA (1-412aa) -F corresponding to the light-control element and the primer GAL4BD-R were used to amplify the target fragment; after the bacterial solution was expanded and the recombinant plasmid was extracted, it was digested with BamH I for verification; The above expression vector was digested with Sac I to obtain a linearized vector. After the linearized vector was recombined with the light-controlled element IV or V and the artificially synthesized VP64 gene, a single clone was picked on a plate for colony PCR identification, and the target fragment was amplified using one of FHY1 (1-202aa) -F or FHY1 (167-202aa) -F and the gene VP64-R as primers; after the bacterial liquid was expanded and the recombinant plasmid was extracted, Sac I was used for enzyme digestion verification.
5. Use of the light control system according to claim 2 in producing terpenoid compounds.
6. The use according to claim 5, It is characterized in that The terpenoid compounds include but are not limited to β-carotene, α-carotene, lycopene, zeaxanthin, and lutein.
7. A fermentation method for constructing a terpene-producing Saccharomyces cerevisiae strain, comprising the following steps: Pick the correct positive monoclonal strain and culture it in SD-Met-URA medium to prepare fermentation seed liquid, and transfer the seed liquid to YPD medium at a 5% inoculum for culture; Transfer the Saccharomyces cerevisiae containing the light-controlled inducible plasmid and test the red light response performance. The culture medium is SD-Met-URA3, and the liquid volume is 25 / 100; culture in a constant temperature shaker equipped with a red light lamp for 72-120 hours, with light on every 1-6 hours and stop light for 1-6 hours; take samples to measure RFU and OD 600 Value, to evaluate the induction effect.
8. Use of the light-controlled system according to claim 2 in producing steroidal compounds.
9. The use according to claim 8, It is characterized in that Steroidal compounds include but are not limited to the vitamin D3 precursor 7-DHC.
10. A fermentation method for constructing a steroid-producing Saccharomyces cerevisiae strain, comprising the following steps: Pick the correct positive monoclonal strain and culture it in SD-Met-URA medium to prepare fermentation seed liquid, and transfer the seed liquid to YPD medium at a 5% inoculum for culture; Transfer the Saccharomyces cerevisiae containing the light-controlled inducible plasmid and test the red light response performance. The culture medium is SD-Met-URA3, and the liquid volume is 25 / 100; culture in a constant temperature shaker equipped with a red light lamp for 48-120 hours, with light on every 1-12 hours and stop light for 1-12 hours; take samples to measure RFU and OD 600 Value, to evaluate the induction effect.
